Trastuzumab Emtansine | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Trastuzumab Emtansine
Europe

PharmaCompass Sponsored Ads

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

Inke S.A: APIs manufacturing plant.

Contact Supplier

Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Trastuzumab Emtansine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 3 Listed Suppliers

3 API Suppliers
3 Listed Suppliers

DEVELOPMENTS

39 Drugs in Development

39 Drugs in Development

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers, 10 Europe, 2 Canada, 8 Australia, 2 South Africa

22 FDF Dossiers
10 Europe
2 Canada
8 Australia
2 South Africa

DIGITAL CONTENT

16 News #PharmaBuzz

16 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 Annual Reports

11 Annual Reports

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

10 All

01 2Roche Pharma (Switzerland) Ag

02 8Roche Registration Gmbh

filter Active Ingredients Reset all filters

10 All

01 10Trastuzumab Emtansine

filter Dosage Form Reset all filters

10 All

01 6Powder For Concentrate For Infusion Solution

02 4Powder For Concentrate For Solution For Infusion

filter Country Reset all filters

10 All

01 6Spain

02 2Sweden

03 2Switzerland

filter Brand Name Reset all filters

10 All

01 10Kadcyla

LGM Trastuzumab emtansine

List of Suppliers

Product Main Page

01

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 15/11/2013

Application Number : 20121010000058

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 160mg

Packaging :

Approval Date : 15/11/2013

Application Number : 20121010000065

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Roche Pharma (Switzerland) Ag

Aus. Peptide Conference

Not Confirmed

Roche Pharma (Switzerland) Ag

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 02/05/2013

Application Number : 62892

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Roche Pharma (Switzerland) Ag

Aus. Peptide Conference

Not Confirmed

Roche Pharma (Switzerland) Ag

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 160mg

Packaging :

Approval Date : 02/05/2013

Application Number : 62892

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 2013-12-26

Application Number : 113885001

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 160MG

Packaging :

Approval Date : 2020-11-03

Application Number : 113885002IP

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 2024-05-22

Application Number : 113885001IP1

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 160MG

Packaging :

Approval Date : 2024-05-22

Application Number : 113885002IP1

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 160MG

Packaging :

Approval Date : 2013-12-26

Application Number : 113885002

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Roche Registration Gmbh

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 2020-11-03

Application Number : 113885001IP

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!